Mitchell Taylor

Mitchell graduated from the University of Sydney with 1st Class Honours in 2012. From day 1 Mitchell sparked an interested in cardiopulmonary physiotherapy (working with the lungs) which is something of a rarity within the field. Struck by his passion to provide the best lung physiotherapy Mitchell travelled across to London to work with some of the worlds leading cardiopulmonary physiotherapists. Since returning from his travels Mitchell has further sculpted his skills working with international specialists such as Bradcliff, Mary Massery, The Alfred and has now brought his unique skill set back to his home towns of Sydney and Wollongong.

Professional Experience


APA Titled Cardiorespiratory Physiotherapist Candidate - Australian Physiotherapy Association


Deputy Chair, NSW Cardiorespiratory APA Committee
Associate Member, Thoracic Society of Australia and New Zealand
Keynote Speaker, Cardiorespiratory Physiotherapy in Private Practice Level 1 and 2
Associate Lecturer, Bradcliff Method
Associate Lecturer, Trust-Me Ed


Bachelor of Applied Science (Physiotherapy) Honours 1st Class - University of Sydney, Australia
Masters of Philosophy (Health and Medicine) Candidate - University of Sydney Australia


  • Lead Physiotherapist and Founder - Functional Lungs (2015-present)
  • Senior Physiotherapist  - Sleep and Respiratory Department - St George Hospital Sydney (2016 - present)
  • Senior Physiotherapist  - Respiratory Co-ordinated Care Program - St George Hospital Sydney (2015-2018)
  • Senior Cardiopulmonary Physiotherapist - St Barts Hospital - London (2014 - 2015)
  • Senior Intensive Care and Paediatric Physiotherapist - Shoalhaven Hospital, Nowra (2013 - 2014)

Advanced Training:

  • Bradcliff Method
  • Mary Massery Trainer
  • Airway Clearance Across the Lifespan (The Alfred)
  • Advanced Tracheostomy Training (St Barts NHS Trust)
  • Musculoskeletal Physiotherapy In Lung Disease (The Alfred)


  • A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of
    Brensocatib Administered Once Daily for 52 Weeks in Subjects With Non-Cystic Fibrosis Bronchiectasis – The ASPEN Study - Clinical Trial Coordinator

Domestic/International Presentations

  • 'COPD in 2023' World COPD Day 2023 - Lung Foundation Australia in partnership with European Lung Foundation, Asthma and Lung UK and Global Initiative for COPD
  • 'Respiratory physiotherapy in private practice: an audit of clinical practice and quality of life outcomes in patients with bronchiectasis' World Bronchiectasis and NTM Conference (2022)
  • 'A Physiotherapists perspective on Exercise rehabilitation in Pulmonary Arterial Hypertension' PHSANZ, Sydney Australia (2020)
  • 'Efficacy of a Chinese Speaking Pulmonary Rehabilitation Program' APSRS Melbourne, Australia (2019)
  • 'The role of physiotherapy in lung disease' Keynote Speaker, Lung Foundation Australia Patient Conference, Sydney Australia (2018)